NeuroPace Inc
NPCE- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001528287
In the last 90 days, NeuroPace Inc insiders filed 3 open-market purchases and 0 sales; 104 institutions reported holding it in 13F filings for Q3 2026, worth $369.0M in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 13, 2026, 1:20 AM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net loss for FY2025: $21.5M (21.5% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Mar 3, 2026 | Jan 8, 2025 | Jan 8, 2024 | Jan 9, 2023 | Jan 11, 2022 |
| Revenue | $100.0M | $79.9M | $65.4M | $45.5M | $45.2M |
| Cost of revenue | $22.8M | $20.8M | $17.3M | $13.0M | $11.7M |
| Gross profit | $77.2M | $59.1M | $48.1M | $32.5M | $33.4M |
| Operating expenses | $93.6M | $80.8M | $75.3M | $73.3M | $57.2M |
| Research and development | $27.9M | $23.7M | $20.8M | $21.9M | $18.2M |
| Selling, general and administrative | $19.1M | $57.1M | $54.5M | $51.3M | $39.0M |
| Operating income | -$16.3M | -$21.7M | -$27.2M | -$40.8M | -$23.7M |
| Interest expense | – | – | $8.52M | $7.53M | $7.41M |
| Income tax | $0 | – | – | – | – |
| Net income | -$21.5M | -$27.1M | -$33.0M | -$47.1M | -$36.1M |
| EPS, basic | $-0.66 | $-0.93 | $-1.27 | $-1.91 | $-2.17 |
| EPS, diluted | $-0.66 | $-0.93 | $-1.27 | $-1.91 | $-2.17 |
| Weighted shares, basic | 32.7M | 29.1M | 25.9M | 24.6M | 16.6M |
| Weighted shares, diluted | 32.7M | 29.1M | 25.9M | 24.6M | 16.6M |
| Margins and growth | |||||
| Gross margin | 77.2% | 73.9% | 73.6% | 71.4% | 74.0% |
| Operating margin | -16.3% | -27.1% | -41.5% | -89.6% | -52.5% |
| Net margin | -21.5% | -34.0% | -50.4% | -103.4% | -79.9% |
| Revenue growth, year over year | +25.1% | +22.1% | +43.7% | +0.7% | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Mar 3, 2026 | Jan 8, 2025 | Jan 8, 2024 | Jan 9, 2023 | Jan 11, 2022 |
| Cash and equivalents | $21.7M | $13.4M | $18.1M | $6.61M | $19.2M |
| Short-term investments | $39.4M | $39.3M | $48.4M | $70.8M | $96.4M |
| Accounts receivable | $14.7M | $12.9M | $12.3M | $7.48M | $7.09M |
| Inventory | $16.9M | $13.4M | $11.2M | $9.71M | $7.82M |
| Total current assets | $94.1M | $81.3M | $92.7M | $97.7M | $132.8M |
| Property, plant and equipment | $1.13M | $1.05M | $1.00M | $1.06M | $603.0K |
| Total assets | $105.6M | $94.6M | $107.7M | $114.1M | $133.6M |
| Accounts payable | $2.22M | $2.95M | $2.33M | $2.15M | $1.38M |
| Short-term debt | – | – | – | – | $0 |
| Total current liabilities | $17.8M | $15.2M | $16.2M | $11.0M | $9.30M |
| Long-term debt | $58.9M | $59.5M | $57.0M | $52.9M | $49.8M |
| Total liabilities | $86.5M | $86.6M | $87.0M | $79.3M | $60.1M |
| Shareholders' equity | $19.0M | $8.01M | $20.7M | $34.8M | $73.5M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Mar 3, 2026 | Jan 8, 2025 | Jan 8, 2024 | Jan 9, 2023 | Jan 11, 2022 |
| Operating cash flow | -$11.0M | -$17.9M | -$19.7M | -$36.9M | -$24.6M |
| Capital expenditures | $332.0K | $306.0K | $173.0K | $603.0K | $384.0K |
| Free cash flow | -$11.3M | -$18.3M | -$19.9M | -$37.5M | -$25.0M |
| Stock-based compensation | $11.1M | $10.3M | $9.56M | $8.35M | $4.29M |
| Share buybacks | $49.5M | – | – | – | – |
| Investing cash flow | -$332.0K | $8.99M | $23.0M | $23.8M | -$85.4M |
| Financing cash flow | $19.6M | $4.33M | $8.13M | $490.0K | $102.5M |
| Net change in cash | $8.26M | -$4.63M | $11.5M | -$12.6M | -$7.45M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 11.1% | 12.9% | 14.6% | 18.3% | 9.5% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Nov 10, 2026 | 34.5M | +3.4% | SEC |
| Aug 7, 2026 | 34.3M | +3.8% | SEC |
| May 8, 2026 | 34.1M | +3.9% | SEC |
| Feb 27, 2026 | 33.7M | +3.4% | SEC |
| Oct 31, 2025 | 33.3M | +11.6% | SEC |
| Aug 8, 2025 | 33.1M | +13.3% | SEC |
| May 9, 2025 | 32.8M | +14.0% | SEC |
| Feb 28, 2025 | 32.6M | +14.9% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.